Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: From Investor Relations...yaz
14
Dec 14, 2012 04:31PM

Dec 14, 2012 04:54PM

thanks for sharing. I guess their litigation counsel forgot to give PTSC and Alliacense that bit of advice when they announced.

And on June 12, 2012, the US District Court for the Northern District of California issued a “Markman” ruling, remarkable for its resounding defeat of the last-remaining ground being clung to by a recalcitrant group of unlicensed, serial infringers. In so doing, the Court aligns with the MMP Portfolio’s 2006 Markman victory, handed down by Judge Ward in the US District Court for the Eastern District of Texas, and decisively confirms the claim construction arguments of the Alliacense Team.

http://www.alliacense.com/13-companies-cited-for-infringement-of-mmp-portfolio-in-itc-complaint/

Share
New Message
Please login to post a reply